vs

Side-by-side financial comparison of ACNB CORP (ACNB) and Inogen Inc (INGN). Click either name above to swap in a different company.

Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $47.2M, roughly 1.5× ACNB CORP). On growth, ACNB CORP posted the faster year-over-year revenue change (42.2% vs 3.4%). ACNB CORP produced more free cash flow last quarter ($52.6M vs $-1.9M). Over the past eight quarters, ACNB CORP's revenue compounded faster (22.1% CAGR vs 4.2%).

ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

ACNB vs INGN — Head-to-Head

Bigger by revenue
INGN
INGN
1.5× larger
INGN
$68.6M
$47.2M
ACNB
Growing faster (revenue YoY)
ACNB
ACNB
+38.8% gap
ACNB
42.2%
3.4%
INGN
More free cash flow
ACNB
ACNB
$54.5M more FCF
ACNB
$52.6M
$-1.9M
INGN
Faster 2-yr revenue CAGR
ACNB
ACNB
Annualised
ACNB
22.1%
4.2%
INGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACNB
ACNB
INGN
INGN
Revenue
$47.2M
$68.6M
Net Profit
$10.8M
Gross Margin
51.4%
Operating Margin
27.9%
-13.6%
Net Margin
22.9%
Revenue YoY
42.2%
3.4%
Net Profit YoY
63.8%
EPS (diluted)
$1.10
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNB
ACNB
INGN
INGN
Q4 25
$47.2M
$68.6M
Q3 25
$50.9M
$79.1M
Q2 25
$50.3M
$79.2M
Q1 25
$43.5M
$68.5M
Q4 24
$33.2M
$66.3M
Q3 24
$34.1M
$74.9M
Q2 24
$33.3M
$74.4M
Q1 24
$31.6M
$63.1M
Net Profit
ACNB
ACNB
INGN
INGN
Q4 25
$10.8M
Q3 25
$14.9M
$-5.3M
Q2 25
$11.6M
$-4.2M
Q1 25
$-272.0K
$-6.2M
Q4 24
$6.6M
Q3 24
$7.2M
$-6.0M
Q2 24
$11.3M
$-5.6M
Q1 24
$6.8M
$-14.6M
Gross Margin
ACNB
ACNB
INGN
INGN
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Q1 24
54.5%
Operating Margin
ACNB
ACNB
INGN
INGN
Q4 25
27.9%
-13.6%
Q3 25
37.2%
-9.0%
Q2 25
29.7%
-7.7%
Q1 25
-1.3%
-11.2%
Q4 24
24.8%
-17.2%
Q3 24
27.6%
-10.4%
Q2 24
42.8%
-9.5%
Q1 24
26.9%
-25.8%
Net Margin
ACNB
ACNB
INGN
INGN
Q4 25
22.9%
Q3 25
29.2%
-6.7%
Q2 25
23.2%
-5.2%
Q1 25
-0.6%
-9.0%
Q4 24
19.9%
Q3 24
21.1%
-8.0%
Q2 24
33.9%
-7.5%
Q1 24
21.4%
-23.1%
EPS (diluted)
ACNB
ACNB
INGN
INGN
Q4 25
$1.10
$-0.26
Q3 25
$1.42
$-0.20
Q2 25
$1.11
$-0.15
Q1 25
$-0.03
$-0.25
Q4 24
$0.77
$-0.41
Q3 24
$0.84
$-0.25
Q2 24
$1.32
$-0.24
Q1 24
$0.80
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNB
ACNB
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$65.6M
$103.7M
Total DebtLower is stronger
$255.4M
Stockholders' EquityBook value
$420.0M
$192.2M
Total Assets
$3.2B
$298.6M
Debt / EquityLower = less leverage
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNB
ACNB
INGN
INGN
Q4 25
$65.6M
$103.7M
Q3 25
$102.1M
$106.5M
Q2 25
$103.1M
$103.7M
Q1 25
$123.6M
$118.9M
Q4 24
$47.3M
$113.8M
Q3 24
$58.1M
$105.7M
Q2 24
$86.3M
$97.9M
Q1 24
$53.1M
$107.4M
Total Debt
ACNB
ACNB
INGN
INGN
Q4 25
$255.4M
Q3 25
$255.4M
Q2 25
$255.4M
Q1 25
$255.3M
Q4 24
$255.3M
Q3 24
$255.3M
Q2 24
$255.3M
Q1 24
$255.3M
Stockholders' Equity
ACNB
ACNB
INGN
INGN
Q4 25
$420.0M
$192.2M
Q3 25
$408.6M
$197.2M
Q2 25
$395.2M
$199.5M
Q1 25
$386.9M
$198.0M
Q4 24
$303.3M
$173.9M
Q3 24
$306.8M
$185.4M
Q2 24
$289.3M
$187.6M
Q1 24
$279.9M
$191.9M
Total Assets
ACNB
ACNB
INGN
INGN
Q4 25
$3.2B
$298.6M
Q3 25
$3.3B
$307.0M
Q2 25
$3.3B
$312.0M
Q1 25
$3.3B
$308.4M
Q4 24
$2.4B
$296.2M
Q3 24
$2.4B
$306.2M
Q2 24
$2.5B
$308.9M
Q1 24
$2.4B
$315.6M
Debt / Equity
ACNB
ACNB
INGN
INGN
Q4 25
0.61×
Q3 25
0.62×
Q2 25
0.65×
Q1 25
0.66×
Q4 24
0.84×
Q3 24
0.83×
Q2 24
0.88×
Q1 24
0.91×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNB
ACNB
INGN
INGN
Operating Cash FlowLast quarter
$53.6M
$-943.0K
Free Cash FlowOCF − Capex
$52.6M
$-1.9M
FCF MarginFCF / Revenue
111.4%
-2.8%
Capex IntensityCapex / Revenue
2.3%
1.4%
Cash ConversionOCF / Net Profit
4.96×
TTM Free Cash FlowTrailing 4 quarters
$92.2M
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNB
ACNB
INGN
INGN
Q4 25
$53.6M
$-943.0K
Q3 25
$23.2M
$2.2M
Q2 25
$17.8M
$4.3M
Q1 25
$-71.0K
$-16.8M
Q4 24
$39.8M
$-3.0M
Q3 24
$13.6M
$7.0M
Q2 24
$9.7M
$6.7M
Q1 24
$10.8M
$-4.7M
Free Cash Flow
ACNB
ACNB
INGN
INGN
Q4 25
$52.6M
$-1.9M
Q3 25
$22.8M
$1.6M
Q2 25
$17.6M
$3.7M
Q1 25
$-730.0K
$-17.1M
Q4 24
$38.8M
$-3.3M
Q3 24
$13.3M
$5.3M
Q2 24
$9.4M
$6.6M
Q1 24
$10.7M
$-6.1M
FCF Margin
ACNB
ACNB
INGN
INGN
Q4 25
111.4%
-2.8%
Q3 25
44.7%
2.0%
Q2 25
35.0%
4.6%
Q1 25
-1.7%
-24.9%
Q4 24
117.0%
-5.0%
Q3 24
39.1%
7.1%
Q2 24
28.3%
8.9%
Q1 24
33.9%
-9.6%
Capex Intensity
ACNB
ACNB
INGN
INGN
Q4 25
2.3%
1.4%
Q3 25
0.8%
0.7%
Q2 25
0.4%
0.9%
Q1 25
1.5%
0.4%
Q4 24
2.9%
0.5%
Q3 24
0.7%
2.2%
Q2 24
0.9%
0.1%
Q1 24
0.2%
2.1%
Cash Conversion
ACNB
ACNB
INGN
INGN
Q4 25
4.96×
Q3 25
1.56×
Q2 25
1.52×
Q1 25
Q4 24
6.03×
Q3 24
1.88×
Q2 24
0.86×
Q1 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACNB
ACNB

Segment breakdown not available.

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons